This inventor holds 2 USPTO granted patents. Top assignee: Pierre Fabre Medicament. Active years: 2000-2003.
Company Filing History:
Years Active: 2000-2003
Title: Thien N'Guyen Ngoc: Innovator in Immunogenic Research
Introduction
Thien N'Guyen Ngoc is a notable inventor based in Saint-Julien-en-Genevois, France. He has made significant contributions to the field of immunogenic research, particularly in relation to respiratory syncytial virus (RSV). With a total of 2 patents, his work has implications for pharmaceutical compositions and immunogenic agents.
Latest Patents
Thien N'Guyen Ngoc's latest patents include a peptide fragment of respiratory syncytial virus protein G, which serves as an immunogenic agent. This polypeptide is characterized by its sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or the bovine respiratory syncytial virus. The patent also discloses methods for preparing and using this immunogenic agent or pharmaceutical composition.
Career Highlights
Thien N'Guyen Ngoc is currently associated with Pierre Fabre Medicament, where he continues to advance his research in immunogenic agents. His work is crucial in developing effective treatments for respiratory infections caused by RSV.
Collaborations
Thien has collaborated with notable colleagues such as Thierry Baussant and Michel Trudel, contributing to a dynamic research environment that fosters innovation.
Conclusion
Thien N'Guyen Ngoc's contributions to immunogenic research highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving health outcomes.